ESMO 2021 Efficacy and Safety of Tepotinib in Patients With Advanced Age: VISION Subgroup Analysis of Pts With MET Exon 14 Skipping NSCLC

40 views
October 20, 2021
Comments 0
Login to view comments. Click here to Login